Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Blood Cancer Journal (9)
Leukemia (5)
Scientific Reports (3)
Nature Communications (1)
Nature Medicine (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (15)
Correspondence (4)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Biomarkers
Cancer
Cell biology
Diseases
Genetics
Health care
Materials science
Medical research
Molecular biology
Nanoscience and technology
Risk factors

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–19 of 19 results

Advanced filters: Author: Silvia Betti Clear advanced filters

Metabolic profiling of therapy-induced senescent cancer cells via TPEF, MALDI-MS, and RNA-sequencing

Silvia Ghislanzoni
Federica Padelli
Italia Bongarzone
ResearchOpen Access17 Dec 2025
Scientific Reports

Volume: 16, P: 1-14
Enabling water-based high-density nanoparticles assembly by using silk fibroin as an adsorbate

Water-based fabrication is of potential use for a range of applications, but can be challenging. Here, the authors report the use of silk fibroin as an absorbate for the preparation of high density nanoparticle layers by water-based processing.

Taehoon Kim
Chungman Kim
Fiorenzo G. Omenetto
ResearchOpen Access10 Feb 2026
Nature Communications

Volume: 17, P: 1-10
A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosis

Alessandra Carobbio
Paola Guglielmelli
Tiziano Barbui
ResearchOpen Access14 Oct 2020
Blood Cancer Journal

Volume: 10, P: 1-7
Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases

Valerio De Stefano
Elena Rossi
Tiziano Barbui
ResearchOpen Access12 Nov 2018
Blood Cancer Journal

Volume: 8, P: 1-7
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis

Paola Guglielmelli
Alessandra Carobbio
Tiziano Barbui
ResearchOpen Access25 Feb 2020
Blood Cancer Journal

Volume: 10, P: 1-8
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine

Aurelio Cafaro
Antonella Caputo
Barbara Ensoli
Research01 Jun 1999
Nature Medicine

Volume: 5, P: 643-650
Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients

Tiziano Barbui
Valerio De Stefano
John Mascarenhas
Research19 May 2021
Leukemia

Volume: 35, P: 2989-2993
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis

Paola Guglielmelli
Giuseppe G. Loscocco
Alessandro M. Vannucchi
ResearchOpen Access11 Dec 2021
Blood Cancer Journal

Volume: 11, P: 1-9
Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study

Tiziano Barbui
Arianna Ghirardi
Guido Finazzi
Research29 May 2019
Leukemia

Volume: 33, P: 1996-2005
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

Tiziano Barbui
Alessandro Maria Vannucchi
Alessandro Rambaldi
Research07 Jan 2021
Leukemia

Volume: 35, P: 485-493
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients

Mattia Bellan
Giuseppe Patti
Pier Paolo Sainaghi
ResearchOpen Access26 Nov 2020
Scientific Reports

Volume: 10, P: 1-10
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19

Tiziano Barbui
Valerio De Stefano
Alessandro Maria Vannucchi
ResearchOpen Access04 Feb 2021
Blood Cancer Journal

Volume: 11, P: 1-11
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B₂ assay as an evaluation tool of different aspirin dosing regimens in the clinical setting

Valerio De Stefano
Bianca Rocca
Carlo Patrono
ResearchOpen Access01 Jun 2018
Blood Cancer Journal

Volume: 8, P: 1-9
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms

Valerio De Stefano
Alessandra Carobbio
Tiziano Barbui
ResearchOpen Access28 Feb 2018
Blood Cancer Journal

Volume: 8, P: 1-12
The incremental value of computed tomography of COVID-19 pneumonia in predicting ICU admission

Maurizio Bartolucci
Matteo Benelli
Adriano Viviani
ResearchOpen Access02 Aug 2021
Scientific Reports

Volume: 11, P: 1-8
Long-term follow-up of recovered MPN patients with COVID-19

Tiziano Barbui
Alessandra Iurlo
Alessandro Rambaldi
CorrespondenceOpen Access16 Jun 2021
Blood Cancer Journal

Volume: 11, P: 1-4
Breakthrough infections in MPN-COVID vaccinated patients

Tiziano Barbui
Alessandra Carobbio
Alessandro Maria Vannucchi
CorrespondenceOpen Access15 Nov 2022
Blood Cancer Journal

Volume: 12, P: 1-6
Second versus first wave of COVID-19 in patients with MPN

Tiziano Barbui
Alessandra Iurlo
Alessandro Maria Vannucchi
Correspondence21 Jan 2022
Leukemia

Volume: 36, P: 897-900
Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirin

Tiziano Barbui
Arianna Ghirardi
Alessandro Rambaldi
Correspondence07 Nov 2019
Leukemia

Volume: 34, P: 1208-1209